← Back to Analyst Consensus 
NSRX Buy
Nasus Pharma Ltd
Current Price —
Implied Upside —
Analysts 8
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Mar 26, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 46% |
| Dec 18, 2025 | Citizens | initiate | — → Market Outperform | $19 | 46% |
| Sep 29, 2025 | Laidlaw & Co. | initiate | — → Buy | $22 | 20% |
Price Target Trend
Mar 28, 2026 Oct 26, 2026
EPS Estimates
0q —
0y —
+1q —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days